vs
Emerald Holding, Inc.(EEX)与PUMA BIOTECHNOLOGY, INC.(PBYI)财务数据对比。点击上方公司名可切换其他公司
Emerald Holding, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.8倍($132.7M vs $75.5M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs 24.3%),PUMA BIOTECHNOLOGY, INC.自由现金流更多($14.4M vs $11.7M),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs -0.3%)
TVS Emerald Haven地产有限公司是一家印度房地产开发企业,总部位于泰米尔纳德邦金奈,为TVS控股旗下子公司,专注于打造可持续居住社区以及各类城市开发项目,在印度本土房地产业务领域拥有清晰的业务定位。
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
EEX vs PBYI — 直观对比
营收规模更大
EEX
是对方的1.8倍
$75.5M
营收增速更快
PBYI
高出3.5%
24.3%
自由现金流更多
PBYI
多$2.7M
$11.7M
两年增速更快
PBYI
近两年复合增速
-0.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $132.7M | $75.5M |
| 净利润 | $-30.2M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | -11.8% | 22.7% |
| 净利率 | -22.8% | — |
| 营收同比 | 24.3% | 27.7% |
| 净利润同比 | -692.2% | — |
| 每股收益(稀释后) | $-0.15 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
EEX
PBYI
| Q4 25 | $132.7M | $75.5M | ||
| Q3 25 | $77.5M | $54.5M | ||
| Q2 25 | $105.5M | $52.4M | ||
| Q1 25 | $147.7M | $46.0M | ||
| Q4 24 | $106.8M | $59.1M | ||
| Q3 24 | $72.6M | $80.5M | ||
| Q2 24 | $86.0M | $47.1M | ||
| Q1 24 | $133.4M | $43.8M |
净利润
EEX
PBYI
| Q4 25 | $-30.2M | — | ||
| Q3 25 | $-14.4M | $8.8M | ||
| Q2 25 | $-1.4M | $5.9M | ||
| Q1 25 | $15.3M | $3.0M | ||
| Q4 24 | $5.1M | — | ||
| Q3 24 | $-11.1M | $20.3M | ||
| Q2 24 | $-2.8M | $-4.5M | ||
| Q1 24 | $11.0M | $-4.8M |
毛利率
EEX
PBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率
EEX
PBYI
| Q4 25 | -11.8% | 22.7% | ||
| Q3 25 | -10.1% | 17.6% | ||
| Q2 25 | 9.7% | 12.7% | ||
| Q1 25 | 24.2% | 8.7% | ||
| Q4 24 | 19.5% | 22.6% | ||
| Q3 24 | -6.5% | 27.4% | ||
| Q2 24 | 7.4% | -4.6% | ||
| Q1 24 | 18.2% | -5.3% |
净利率
EEX
PBYI
| Q4 25 | -22.8% | — | ||
| Q3 25 | -18.6% | 16.2% | ||
| Q2 25 | -1.3% | 11.2% | ||
| Q1 25 | 10.4% | 6.5% | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | -15.3% | 25.2% | ||
| Q2 24 | -3.3% | -9.6% | ||
| Q1 24 | 8.2% | -11.0% |
每股收益(稀释后)
EEX
PBYI
| Q4 25 | $-0.15 | $0.26 | ||
| Q3 25 | $-0.07 | $0.17 | ||
| Q2 25 | $-0.01 | $0.12 | ||
| Q1 25 | $0.08 | $0.06 | ||
| Q4 24 | $0.01 | $0.40 | ||
| Q3 24 | $-0.05 | $0.41 | ||
| Q2 24 | $-0.03 | $-0.09 | ||
| Q1 24 | $0.00 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $100.9M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $338.8M | $130.3M |
| 总资产 | $1.2B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势,按日历期对齐
现金及短期投资
EEX
PBYI
| Q4 25 | $100.9M | $97.5M | ||
| Q3 25 | $95.4M | $94.4M | ||
| Q2 25 | $156.4M | $96.0M | ||
| Q1 25 | $276.8M | $93.2M | ||
| Q4 24 | $194.8M | $101.0M | ||
| Q3 24 | $188.9M | $96.7M | ||
| Q2 24 | $193.2M | $96.8M | ||
| Q1 24 | $186.8M | $107.2M |
总债务
EEX
PBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益
EEX
PBYI
| Q4 25 | $338.8M | $130.3M | ||
| Q3 25 | $369.5M | $115.3M | ||
| Q2 25 | $389.4M | $104.7M | ||
| Q1 25 | $392.1M | $97.1M | ||
| Q4 24 | $385.9M | $92.1M | ||
| Q3 24 | $391.1M | $71.1M | ||
| Q2 24 | $407.6M | $48.5M | ||
| Q1 24 | $-90.7M | $51.0M |
总资产
EEX
PBYI
| Q4 25 | $1.2B | $216.3M | ||
| Q3 25 | $1.2B | $202.9M | ||
| Q2 25 | $1.2B | $194.9M | ||
| Q1 25 | $1.2B | $196.2M | ||
| Q4 24 | $1.0B | $213.3M | ||
| Q3 24 | $1.1B | $220.7M | ||
| Q2 24 | $1.1B | $205.0M | ||
| Q1 24 | $1.1B | $214.1M |
负债/权益比
EEX
PBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $12.3M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $11.7M | $14.4M |
| 自由现金流率自由现金流/营收 | 8.8% | 19.1% |
| 资本支出强度资本支出/营收 | 0.5% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.4M | $41.7M |
8季度趋势,按日历期对齐
经营现金流
EEX
PBYI
| Q4 25 | $12.3M | $14.4M | ||
| Q3 25 | $1.8M | $9.7M | ||
| Q2 25 | $15.9M | $14.1M | ||
| Q1 25 | $12.6M | $3.6M | ||
| Q4 24 | $20.6M | $15.6M | ||
| Q3 24 | $9.1M | $11.0M | ||
| Q2 24 | $9.8M | $1.0M | ||
| Q1 24 | $7.3M | $11.2M |
自由现金流
EEX
PBYI
| Q4 25 | $11.7M | $14.4M | ||
| Q3 25 | $1.5M | $9.7M | ||
| Q2 25 | $15.8M | $14.1M | ||
| Q1 25 | $12.4M | $3.6M | ||
| Q4 24 | $19.9M | $15.6M | ||
| Q3 24 | $9.0M | $11.0M | ||
| Q2 24 | $9.6M | $1.0M | ||
| Q1 24 | $7.0M | — |
自由现金流率
EEX
PBYI
| Q4 25 | 8.8% | 19.1% | ||
| Q3 25 | 1.9% | 17.7% | ||
| Q2 25 | 15.0% | 26.8% | ||
| Q1 25 | 8.4% | 7.7% | ||
| Q4 24 | 18.6% | 26.4% | ||
| Q3 24 | 12.4% | 13.7% | ||
| Q2 24 | 11.2% | 2.1% | ||
| Q1 24 | 5.2% | — |
资本支出强度
EEX
PBYI
| Q4 25 | 0.5% | 0.0% | ||
| Q3 25 | 0.4% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.7% | 0.0% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.2% | 0.0% | ||
| Q1 24 | 0.2% | 0.0% |
现金转化率
EEX
PBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | 0.82× | 1.21× | ||
| Q4 24 | 4.04× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.66× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EEX
| Connections Segment | $121.9M | 92% |
| Commerce Segment | $5.5M | 4% |
| Content | $5.3M | 4% |
PBYI
暂无分部数据